spacer
home > pmps > summer 2008 > free-flowing innovation
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Free-Flowing Innovation

Interest in more advanced drug delivery systems has increased in line with the acceleration in the discovery and development of novel therapeutic macromolecules for targeted applications. Computational fluid dynamics (CFD) is a design tool that allows designers of these and other products to evaluate different designs rapidly and cost-effectively.

The use of CFD within the pharmaceutical industry has increased in recent years. Its application to the development of a new drug offers significant benefits in terms of yielding reduced costs, faster time to market, an improved understanding of existing or novel innovations, and the knowledge to make informed decisions to help guide and shape the direction of future research efforts.

These benefits are of particular significance in the search for an effective delivery system for a new drug – an issue that has become more pertinent in light of the recent moves away from needle- and syringe-based injection methods. Traditionally, animal experimentation has been used to evaluate drug delivery systems, but the results are not seen as sufficiently reliable when transposed to humans, whose respiratory physiology, for example, can differ greatly. This often leads to dramatically varying doses being realised from the same initial sample, making useful comparisons problematic.

In addition, an obligation exists under law to minimise experimentation on animals, placing restrictions on the level of testing that can be conducted. CFD can help overcome some of these issues, by allowing for the rapid and economic analysis of various drug delivery designs, using a three-dimensional model of human physiology.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Stephen Grant of ANSYS is an engineer with a degree in Manufacturing Systems. He has spent much of his career working in large scale production and manufacture in the automotive industry. He moved into a commercial role as a Systems Integrator looking after a broad range of industries from automotive and defence through to pharmaceutical. Stephen is now responsible for ANSYS’s development and growth in the healthcare sector across the UK.
spacer
Stephen Grant
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Sphere Fluidics introduces latest version of Cyto-Mine Studio Software Suite

Cambridge, UK, 27 August 2019: Sphere Fluidics, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology, today introduced an updated version of its Cyto-Mine® Studio Software Suite, a collection of software controlling operation of its Cyto-Mine Single Cell Analysis System, data acquisition and follow-up analysis. The latest software version includes new functionality to further enhance users’ workflows in biologics discovery and cell line development.
More info >>

White Papers

Future-proofing serialization solutions: the importance of strong level 3 capabilities

Adents

The complexities surrounding product serialization for pharmaceutical and medical device companies are immense. While current serialization requirements are limited to marking the unit of sale with a unique data carrier, by 2023 the process will require a product to be traceable through the entirety of its journey - from the individual package through the carton/pallet to its final point of distribution. In the United States, the Healthcare Distribution Management Association (HDMA) is suggesting that pharmaceutical companies begin to support this level of serialization, called aggregation, now. Around the world – in Europe and Asia in particular – disparate track and trace practices are incrementally moving toward a global standard that will, undoubtedly, be more stringent than today’s differing benchmarks. How can companies manage this transformation with the greatest degree of success while also minimizing business disruption? The key to creating an optimal implementation strategy is to select a serialization solution that has strong capabilities at all levels of technology. It’s also important to choose a solution that enables multi-phase implementation
More info >>

 
Industry Events

SAPHEX 2019

23-24 October 2019, GALLAGHER CONVENTION CENTRE, 10 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, SOUTH AFRICA

SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement